CNXU (CNXU)
9.34
-0.31 (3.21%)
Upcoming Events
Latest Headlines
Form SCHEDULE 13G Conexeu Sciences Inc. Filed by: Paisley Capital Holdings Corp
July 20, 2026 12:33 PM - SEC Filing
A Weight-Loss Revolution Is Reshaping Bodies. This Preclinical Biotech Wants to Build What Comes Next
July 15, 2026 8:45 AM - StreetInsider
The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It
July 14, 2026 8:30 AM - StreetInsider
Form 8-K Conexeu Sciences Inc. For: Jul 07
July 7, 2026 5:13 PM - SEC Filing
A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today’s Injectables Were Not Built to Fill
July 7, 2026 9:00 AM - StreetInsider
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
July 1, 2026 9:05 AM - StreetInsider
Form D Conexeu Sciences Inc.
June 30, 2026 6:03 AM - SEC Filing
Form D Conexeu Sciences Inc.
June 30, 2026 6:03 AM - SEC Filing
Form 3 Conexeu Sciences Inc. For: Jun 15 Filed by: Costa Andrew
June 29, 2026 6:15 AM - SEC Filing
The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
June 25, 2026 9:04 AM - StreetInsider
Conexeu Sciences opens R&D lab at Vancouver's adMare M4 centre
June 25, 2026 8:31 AM - StreetInsider
Conexeu Sciences opens Vancouver R&D lab at adMare M4 centre
June 25, 2026 8:31 AM - StreetInsider
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform
June 25, 2026 8:30 AM - Globe NewsWire
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform
June 25, 2026 8:30 AM - StreetInsider
Form 3 Conexeu Sciences Inc. For: Jun 15 Filed by: Burke April Lynn
June 24, 2026 4:16 PM - SEC Filing
Form 3 Conexeu Sciences Inc. For: Jun 15 Filed by: Bastiani-Posner Ana Lucia
June 23, 2026 9:52 PM - SEC Filing
Form 4 Conexeu Sciences Inc. For: Jun 18 Filed by: Purcell Lynn Sebastian
June 23, 2026 8:16 PM - SEC Filing
Form 4 Conexeu Sciences Inc. For: Jun 18 Filed by: Wright Michael G.
June 22, 2026 1:26 PM - SEC Filing
H.C. Wainwright Starts Conexeu Sciences (CNXU) at Buy
June 22, 2026 6:07 AM - StreetInsider
Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
June 18, 2026 12:43 PM - StreetInsider
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
June 16, 2026 10:30 AM - StreetInsider
Conexeu Sciences expands board to nine after Nasdaq listing
June 16, 2026 8:17 AM - StreetInsider
Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower
June 16, 2026 8:15 AM - PR NewsWire
Form 424B3 Conexeu Sciences Inc.
June 16, 2026 6:03 AM - SEC Filing
Form 10-Q Conexeu Sciences Inc. For: Apr 30
June 15, 2026 4:31 PM - SEC Filing
Conexeu Sciences adds five members to leadership team
June 15, 2026 8:30 AM - StreetInsider
Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing
June 15, 2026 8:30 AM - StreetInsider
Form D/A Conexeu Sciences Inc.
June 12, 2026 2:32 PM - SEC Filing
Form D Conexeu Sciences Inc.
June 10, 2026 3:18 PM - SEC Filing
Form 8-K Conexeu Sciences Inc. For: Jun 04
June 9, 2026 4:31 PM - SEC Filing
A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus
June 9, 2026 9:55 AM - StreetInsider
Conexeu Sciences advances manufacturing for wound care device
June 8, 2026 8:32 AM - StreetInsider
Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program
June 8, 2026 8:30 AM - StreetInsider
Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026
June 3, 2026 8:30 AM - StreetInsider
Form 4 Conexeu Sciences Inc. For: May 26 Filed by: Wright Michael G.
May 28, 2026 11:40 AM - SEC Filing
Form 3 Conexeu Sciences Inc. For: May 11 Filed by: Wright Michael G.
May 27, 2026 2:06 PM - SEC Filing
UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
May 27, 2026 10:36 AM - Globe NewsWire
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
May 27, 2026 9:00 AM - StreetInsider
Form 4 Conexeu Sciences Inc. For: May 22 Filed by: Sharpe Jeffrey Nathan
May 26, 2026 6:16 AM - SEC Filing
The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
May 22, 2026 11:30 AM - StreetInsider
A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching
May 22, 2026 10:09 AM - Globe NewsWire
Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"
May 21, 2026 12:04 PM - StreetInsider
Full Article List
